Hari Mahadevan

Title: The Innovations of Hari Mahadevan

Introduction

Hari Mahadevan is an accomplished inventor based in Annandale, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance drug formulation. His work is characterized by a focus on improving the physical properties of pharmaceutical compounds.

Latest Patents

One of Mahadevan's notable patents is for the "Process for the crystallization of losartan." Losartan potassium is an angiotensin II antagonist that is useful in the treatment of hypertension and congestive heart failure. This invention relates to the process for the controlled crystallization of losartan potassium utilizing anti-solvent addition combined with massive seeding. This method aims to obtain the desired crystal morphology and bulk physical properties necessary for successful formulation. He holds 1 patent in this area.

Career Highlights

Hari Mahadevan is currently employed at Merck & Co., Inc., a leading global healthcare company. His role involves research and development, where he applies his expertise to create innovative solutions in drug formulation. His contributions have been instrumental in advancing the company's pharmaceutical offerings.

Collaborations

Throughout his career, Mahadevan has collaborated with several professionals in the field. Notable coworkers include Karen A Larson and Patrick Breen, who have worked alongside him on various projects.

Conclusion

Hari Mahadevan's work exemplifies the impact of innovation in the pharmaceutical industry. His patent for the crystallization of losartan showcases his commitment to improving drug formulation processes. His contributions continue to influence the development of effective treatments for patients.